Respiratory Rehabilitation
M-A: More than 50 long-term effects of COVID-19.
11 Aug, 2021 | 08:47h | UTCRelated:
Cohort study: Risk factors for long covid in previously hospitalized children.
Viewpoint: The road to addressing Long Covid.
Review: Long covid—mechanisms, risk factors, and management.
Review: Symptoms, complications and management of long COVID.
Studies elucidate poorly understood long COVID.
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
[Preprint] Long Covid: Third of people infected have long term symptoms.
Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report.
Perspective | The four most urgent questions about long COVID.
Systematic review: Frequency, signs and symptoms, and criteria adopted for long COVID-19.
Report: 376,000 people in UK have had long Covid symptoms for at least a year.
One third of patients hospitalized with COVID-19 have lung changes after a year
Perspective | They Tested Negative for Covid. Still, They Have Long Covid Symptoms.
Cohort study: One in ten have long-term effects 8 months following mild COVID-19
Long Covid Implications for the workplace
Long Covid in the UK – More than a million affected in February, survey suggests
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Review | Post-acute COVID-19 syndrome
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Perspective | Long Covid isn’t as unique as we thought
Attributes and predictors of long COVID
WHO Report: Preparing for Long COVID 2021
Long Covid: Sequelae in adults at 6 Months after COVID-19 infection
How many people get ‘long COVID’ – and who is most at risk?
Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline
Patients, clinicians seek answers to the mystery of ‘Long COVID’
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
NICE Guideline: Managing the long-term effects of COVID-19
Commentary on Twitter
Nuestro estudio sobre Covid ?Persistente o de Largo recorrido se ha publicado finalmente en @SciReports
?https://t.co/ATFO5QO3kF pic.twitter.com/qwBikXyqll— Sonia Villapol (@svillapol) August 10, 2021
Systematic Review: Non-invasive ventilation used at night by people with COPD.
10 Aug, 2021 | 08:53h | UTCOriginal review: Chronic non‐invasive ventilation for chronic obstructive pulmonary disease – Cochrane Library
AARC Guideline: Management of pediatric patients with oxygen in the acute care setting.
8 Aug, 2021 | 23:43h | UTC
Pediatric asthma: The REGAP consensus.
8 Aug, 2021 | 23:45h | UTCPediatric asthma: The REGAP consensus – Anales de Pediatría
[Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated with better outcomes.
6 Aug, 2021 | 10:18h | UTCCommentary: Covid: Pressured oxygen reduces ventilator need – BBC
Commentary on Twitter (thread – click for more)
RECOVERY-RS results out, and confirm what most of us have been doing:
CPAP reduces intubation/mortality by 28% compared with no CPAP/HFNO (composite outcome, mostly intubation)
Nasal high flow not so successful1/https://t.co/bcB2sTdAsu pic.twitter.com/fvT8IbyxUr
— ??? ?????? ? (@LawtonTri) August 5, 2021
International, multicenter observational study: Outcomes with percutaneous dilatational tracheotomy in high-risk ICU patients.
6 Aug, 2021 | 08:59h | UTCPercutaneous dilatational tracheotomy in high-risk ICU patients – Annals of Intensive Care
Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”
4 Aug, 2021 | 10:06h | UTCInvited commentary: Citizen science and biomedical research (free registration required)
Commentaries:
Long Covid uncommon in children, analysis finds – King’s College London
Study finds long-term Covid symptoms rare in school-age children – The Guardian
Related:
Cohort study: Risk factors for long covid in previously hospitalized children.
Commentary on Twitter
New @LancetChildAdol is a very reassuring prospective study of >250,000 children, >1700 with + covid test, age 5-17, that shows the risk for chronic Covid symptoms is quite low; 4.4% beyond 4 weekshttps://t.co/XVFs0UtHWC pic.twitter.com/XBVH5wmFve
— Eric Topol (@EricTopol) August 3, 2021
AAP Guidance: Post-COVID-19 conditions in children and adolescents.
4 Aug, 2021 | 10:01h | UTCPost-COVID-19 Conditions in Children and Adolescents – American Academy of Pediatrics
Spontaneous pneumomediastinum in patients diagnosed with covid-19: a case series with review of literature.
4 Aug, 2021 | 09:13h | UTC
RCT: Effect of a sedation and ventilator liberation protocol vs. usual care on duration of invasive mechanical ventilation in pediatric intensive care units.
4 Aug, 2021 | 08:59h | UTCEffect of a Sedation and Ventilator Liberation Protocol vs Usual Care on Duration of Invasive Mechanical Ventilation in Pediatric Intensive Care Units: A Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
In this stepped-wedge, cluster RCT, among infants and children anticipated to require prolonged mechanical ventilation, a sedation & ventilator liberation protocol intervention resulted in a reduction in time to first successful extubation https://t.co/oNuOq9CCrs pic.twitter.com/n9l3MOJlop
— JAMA (@JAMA_current) August 3, 2021
M-A: Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease.
3 Aug, 2021 | 09:09h | UTC
Covid: Pulse oxygen monitors work less well on darker skin, experts say.
3 Aug, 2021 | 09:00h | UTCCovid: Pulse oxygen monitors work less well on darker skin, experts say – BBC
Related:
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias
Viewpoint: The road to addressing Long Covid.
30 Jul, 2021 | 12:09h | UTCThe road to addressing Long Covid – Science (a few articles per month are free)
Related: Review: Long covid—mechanisms, risk factors, and management.
Commentary on Twitter
On #LongCovid, @Dr2NisreenAlwan, a leading authority on this condition, has an exceptional perspective @ScienceMagazine today reviewing what we know, which is grossly insufficient, and what we need to do https://t.co/R7Mf5yEQCx pic.twitter.com/MNWsetLakP
— Eric Topol (@EricTopol) July 29, 2021
Study: Recommended approaches to minimize aerosol dispersion of SARS-CoV-2 during noninvasive ventilatory support can cause ventilator performance deterioration.
30 Jul, 2021 | 11:59h | UTC
Review: Long covid—mechanisms, risk factors, and management.
27 Jul, 2021 | 03:52h | UTCLong covid—mechanisms, risk factors, and management – The BMJ
Commentary on Twitter
Great review in @bmj_latest of what we know – and all that we don't – about Long Covid.
Including this graphic of different ways it can manifest.
article here https://t.co/zsqNVNVEo8 https://t.co/V4C5aJbpg0 pic.twitter.com/5XU1W557wQ
— Prof. Christina Pagel (@chrischirp) July 26, 2021
M-A of randomized trials: Conservative oxygen therapy for critically ill patients.
28 Jul, 2021 | 09:41h | UTC
Review: Personalized mechanical ventilation in acute respiratory distress syndrome.
22 Jul, 2021 | 10:40h | UTCPersonalized mechanical ventilation in acute respiratory distress syndrome – Critical Care
Related: M-A of randomized trials: In patients with acute respiratory distress syndrome, there was no difference in mortality between higher vs. lower positive end-expiratory pressure strategies. AND Seminar | Acute respiratory distress syndrome. AND Short review: Diagnosis and management of acute respiratory distress syndrome
Review: Symptoms, complications and management of long COVID.
18 Jul, 2021 | 23:46h | UTCCommentary: Long COVID: More likely in patients with 5+ symptoms in first week of infection – SAGE Publications
Commentary on Twitter
Pooled prevalence data in this review showed the 10 most prevalent reported symptoms of long covid were: fatigue, shortness of breath, muscle pain, joint pain, headache, cough, chest pain, altered smell, altered taste and diarrhoea.
https://t.co/ww5HM1s7vm— KK Cheng (@KKCheng4) July 16, 2021
Studies elucidate poorly understood long COVID.
18 Jul, 2021 | 23:42h | UTCStudies elucidate poorly understood long COVID – CIDRAP
Long Covid: fatigue, post-exertional malaise, and cognitive dysfunction are the most common symptoms, according to an international survey.
18 Jul, 2021 | 23:44h | UTCCommentaries: Identification of over 200 long COVID symptoms prompts call for UK screening programme – University College London AND A survey of long-haulers found 66 symptoms that lasted more than 6 months. Tiredness and brain fog were most common. – Insider AND Long Covid has more than 200 symptoms, study finds – The Guardian
M-A of randomized trials: In patients with acute respiratory distress syndrome, there was no difference in mortality between higher vs. lower positive end-expiratory pressure strategies.
16 Jul, 2021 | 10:43h | UTC
Long Covid: 39% of patients report persistent symptoms more than seven months after diagnosis of COVID-19 in an outpatient setting.
13 Jul, 2021 | 09:57h | UTCCommentaries: Long COVID symptoms in a third of people with COVID-19 – American College of Physicians AND Covid-19: 1-in-3 Patients Reported Long-Hauler Symptoms – Physician’s Weekly
Commentary on Twitter
A new prospective cohort study of >400 people with mild to moderate (outpatient) covid at 7-9 months: nearly 1 of 3 had persistent symptoms #LongCovid @AnnalsofIM
https://t.co/ix1Hhsm0iZ
by @mayssamnehme and colleagues pic.twitter.com/Uc4UEclDvA— Eric Topol (@EricTopol) July 5, 2021
[Preprint] Long Covid: Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people.
13 Jul, 2021 | 09:55h | UTCCommentary: Study explores the prevalence of long COVID in England – News Medical
Review: Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.
8 Jul, 2021 | 09:01h | UTC
Commentary on Twitter
Physiology-to-bedside overview about non-invasive ventilatory support in AHRF & #ARDS
➡️spontaneous breathing: benefits/harms
➡️how to make spontaneous effort non‑injurious?
➡️optimizing HFNO & NIV
➡️monitoring to detect failure & be protective
➡️evidencehttps://t.co/KPW2u8akhA pic.twitter.com/yKVxrYaFmZ— Intens Care Med (@yourICM) July 7, 2021
Seminar | Acute respiratory distress syndrome.
5 Jul, 2021 | 01:57h | UTCAcute respiratory distress syndrome – The Lancet